Dalfampridine benefits ambulation but not cognition in multiple sclerosis.
Satchidanand N, Drake A, Smerbeck A, Hojnacki D, Kolb C, Patrick K, Weinstock-Guttman B, Motl R, Benedict RH.
Satchidanand N, et al. Among authors: benedict rh.
Mult Scler. 2020 Jan;26(1):91-98. doi: 10.1177/1352458518815795. Epub 2018 Dec 19.
Mult Scler. 2020.
PMID: 30566030
Clinical Trial.